Mn Services Vermogensbeheer B.V. Novo Cure LTD Transaction History

Mn Services Vermogensbeheer B.V.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 03, 2023	SELL	$63.98 - $85.37 $377,482 - $503,683	-5,900 Reduced 11.39%	45,900 $3.37 Million
Q3 2022 Nov 01, 2022	SELL	$67.99 - $89.57 $278,759 - $367,237	-4,100 Reduced 7.33%	51,800 $3.94 Million
Q2 2022 Aug 03, 2022	SELL	$56.6 - $89.9 $509,400 - $809,100	-9,000 Reduced 13.87%	55,900 $3.89 Million
Q1 2022 May 10, 2022	SELL	$60.15 - $84.52 $204,510 - $287,368	-3,400 Reduced 4.98%	64,900 $5.38 Million
Q3 2021 Nov 03, 2021	BUY	$116.17 - $194.55 $81,319 - $136,185	700 Added 1.04%	68,300 $7.93 Million
Q2 2021 Aug 05, 2021	BUY	$130.4 - $225.58 $8.82 Million - $15.2 Million	67,600 New	67,600 $12.6 Million

262

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.04B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Mn Services Vermogensbeheer B.V., based on Form 13F filings with the SEC.

Stay updated on Mn Services Vermogensbeheer B.V. with notifications on news.